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Abstract
Background: Nonalcoholic fatty liver disease (NAFLD) represents one of the most common forms of liver disease
worldwide, and it is always regarded as a consequence of a sedentary, food-abundant lifestyle, sitting for an
extended time, and a low physical activity level, which often coincide with chronic and long-lasting psychological
stress. A Chinese medicine Sinisan (SNS) may be a potential formula for treating this kind of disease.
Methods: In this study, a long-term chronic restraint stress protocol was used to investigate the mechanism
underlying stress-induced NALFD. To investigate the effect of SNS treatment on stress-induced NAFLD, we
measured the liver and serum values of total cholesterol (TC), triglyceride (TG), liver free fatty acids (FFA), low-
density lipoprotein, superoxide dismutase, tumor necrosis factor-α, malondialdehyde, interleukin (IL)-6, and serum
values of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase. Results are
shown as a mean ± standard deviation. Significant differences between the groups were evaluated using the
Student t-test. For multiple comparisons, one-way analysis of variance (ANOVA) was used. If the results of ANOVA
indicated significant differences, post hoc analysis was performed with the Tukey test or Dunnett test, and p < 0.05
was considered statistically significant.
Results: Long-term chronic stress led to steatosis and non-alcoholic steatohepatitis. Additionally, SNS treatment
significantly increased body weight gain (p < 0.01) and sucrose preference (p < 0.001), and it reduced the liver
values of TC, TG, and FFA (p < 0.05). SNS also reduced the serum values of AST and ALT (p < 0.001), and the liver
value of IL-6 (p < 0.01).
Conclusions: This study’s results demonstrate that psychological stress may be a significant risk factor of NAFLD.
Furthermore, the traditional Chinese medicine formula SNS may have some beneficial effect in antagonizing
psychological stress and stress-related NAFLD.
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Background
Nonalcoholic fatty liver disease (NAFLD) represents one
of the most common forms of liver disease worldwide
[1], and is considered a hepatic manifestation of the
metabolic syndrome [2]. NAFLD refers to a wide
spectrum of liver injuries, ranging from simple fat accu-
mulation (steatosis) to other severe liver diseases such as
non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis,
and hepatocellular carcinoma [3]. The prevalence of
NAFLD has increased remarkably over the last three
decades to nearly 15–30% in the general population in
western countries [4]. Recent data on epidemiology of
NAFLD, suggest that this is the most common liver
disease worldwide. Not only in western Countries, but
also in India, China and sud America [5]. In China, its
prevalence approximately doubled in the past decade
and reached 15–20% in affluent regions [6, 7]. The
mechanism involved in the development of NAFLD is
still under debate, although several hypotheses have been
proposed. One generally accepted theory is the two-hit
hypothesis [8], which suggests that the accumulation of
fat in the liver predisposes the liver to secondary stress
such as oxidative stress, inflammation, and cytokines [9].
Actually, no treatment for NAFLD was codified now-
adays. The international guidelines report that lifestyle
changes are the only therapies suggested in NAFLD
patients, in particular in overweight/obese [10]. How-
ever, many complementary therapies and in particular
herbal medicine, are been studied to treat NAFLD.
The prevalence of NAFLD is always regarded as a con-
sequence of a sedentary, food-abundant lifestyle, sitting
for a long time, and low physical activity level [11, 12],
which often coincide with long-lasting and chronic stress.
Stress is defined as any physical or psychological change
that could interfere with one’s internal environment [13],
thereby increasing the risk of various health problems. It
is also characterized by the activation of the autonomic
nervous system, hypothalamic-pituitary-adrenal axis, and
sympathetic-adrenal-medullary system [14]. In modern
society, which is characterized by a rapid pace of life,
individuals ceaselessly encounter an increasing number of
psychological stressful stimuli such as emotional stimuli
and social stress [15]. It had been validated by clinical
trials that chronic stress from high levels of working pres-
sure and a low quality of life are the risk factors of obesity
and metabolism syndrome [16, 17]. Furthermore, chronic
stress can lead to multiple systemic inflammation, hypoxic
organs, and oxidative stress [18–20]. Thus, it is likely that
chronic stress directly and indirectly promotes the
progression of chronic liver disease. Although some
studies have shown that long-term and repeated chronic
stress affect high-fat diet-induced NAFLD progression
[21], the relationship between chronic stress and NAFLD
is still unclear. Therefore, we are eager to determine
whether chronic stress can lead to NAFLD. Further ex-
ploration into the mechanism of stress-induced NAFLD
will contribute to the discovery of novel therapeutic
targets and the design of optimized treatment strategies
for patients with NAFLD.
Sinisan (SNS), also called Shigyaku-san in Japan, origi-
nated from the book of Shang Han Lun written during the
Han Dynasty (200–201 AD) by a famous Chinese doctor
Zhongjing Zhang, and it comprises four herbal medicines:
Aurantii Immaturus Fructus (Zhi-Shi), Paeonae Alba
Radix (Bai-Shao), Licorice Root (Gan-Cao), and Bupleuri
Radix (Chai-Hu) with a dose proportion of 1:1:1:1 [22].
Some studies have demonstrated its effectiveness against
liver injury [23, 24], hepatitis [25, 26] and Palmoplantar
hidrosis [27]. Actually, SNS is proposed to reverse impair-
ments in spatial learning and memory, reduces aggressive
behavior in rats subjected to chronic restraint stress [28],
and SNS alone was also more effective in reducing
depression-like behavior than fluoxetine alone, and mark-
edly increased central 5-HT and reduced peripheral 5-HT
in model rats [29, 30]. Although there is no proven ther-
apy for NAFLD, an experimental study indicated that SNS
could prevent the course of NASH by adjusting TG distri-
bution in serum and liver, increasing the anti-oxidative
capacity of liver, and reducing the peroxide damage in a
MDC-diet NAFLD model [31]. Otherwise, some compo-
nents of SNS, such as paeoniflorin [32] and glycyrrhetic
acid [33], are reported to have protective effect against
NAFLD in vivo and in vitro NAFLD models. Taken
together, we noticed that SNS may have potential effect
on stress-induced depression, hepatic steatosis and steato-
hepatitis. Therefore, the purposes of the present study
were to compile evidence for this stress-induced NAFLD
hypothesis using the chronic restraint stress (CRS) model
in rats, and to investigate potential therapeutic effects of
SNS for stress-related NAFLD as an alternative and safe
drug for clinical use.
Methods
Preparation of SNS extract
Crude preparations of SP were purchased from Beijing
Tongrentang (Beijing, China). The herbs were authenti-
cated by our team. The SNS extract was prepared ac-
cording to the previous article [34]. This extract
contained flavonoid glycosides (56.36%) and saponins
(12.067%), which were detected by UV. Neohesperidin
(24.547%), naringin (20.2%) and glycyrrhizic acid
(2.654%) were measured by high performance liquid
chromatography coupled to UV detection, which were
consistent with the article.
Experimental animals and treatments
In the present study, 30 male specific-pathogen-free
level Sprague-Dawley rats (weighing 130–150 g) were
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commercially obtained from Vital River Laboratories
(number SCXK 2012–0001), and they were permitted to
acclimate to the environment for 7 days before the ex-
periments began. Then they were randomly assigned to
the control, stress, and SNS treatment groups (n = 10,
respectively). Control rats were left undistributed,
whereas rats in the stress and SNS groups had
chronic stress for 9 weeks. Details of this process are
described in Stress Protocol section. Rats in the con-
trol group and stress group were gavaged with sterile
water at a dose of 10 mL × kg−1 of body weight. Rats
in the SNS group received SNS at a dose of
3.6 g × kg−1 of body weight by gavage. All animals
were treated daily from 8:30–9:00 am. The treatments
lasted for the entire experiment. The animals were
maintained under a standard 12 h light/dark cycle
(lights on at 8:00 a.m.) at a constant temperature of
24 ± 1 °C and relative humidity of 45 ± 15% with
free access to food and distilled water, except for pe-
riods of water and food deprivation.
Stress protocol
The long-term chronic restraint stress procedure was
performed according to a previous study [35] with
minor modifications. This procedure mimics stress
that is largely psychological in nature. In brief, re-
straint stress was applied using a plastic restrainer
(550-mL cubage water bottle, Nongfu Spring Company
Limited and 600-mL cubage water bottle, Danone)
with multiple punctures that enabled it to closely fit
over the mice. The rats were restrained for 6 h per
day for 9 consecutive weeks. The stress procedure
was conducted at the institutional animal facility
throughout the experimental period between 10 am
and 4 pm. Immediately after terminating the stress
exposure, animals returned to their home cages. The
control rats were not disturbed during the 9-week
period, and they remained isolated from the stressed
animals with access to food or water during the same
period of stress to avoid any acoustic or olfactory
communication between the groups. The time sched-
ule for the CRS procedure is shown in Fig. 1.
Experimental procedures
After 9 weeks, all rats were fasted overnight and then
anesthetized using isoflurane. Blood was collected by
orbital puncture, followed by sacrifice through cervical
dislocation. Next, the entire liver was resected. For hist-
ology, a small part of the liver was immediately fixed in
10% formalin and processed for paraffin embedding. The
rest of the liver was stored at −80 °C for further bio-
chemical analysis.
Open-field test
The open-field test (OFT), performed as previously de-
scribed, was used to study the exploratory and anxious
behavior of the rats [36]. The open-field test was con-
ducted between 8:00 am and 12:00 am in a quiet room
(≤60 dB) pre-dosing. The open-field apparatus consisted
of a black square arena (100 cm × 100 cm) with a black
wall (40 cm high). The floor was marked with a grid that
divided the floor into 25 equal-size squares. During a 3-
min observation period, each rat was placed at the
center of the apparatus, and horizontal locomotion (the
number of total squares crossed) and the frequencies of
rearing (defined when the rat stands upright on its hind
legs) were recorded. Each animal was tested using the
apparatus once. Simultaneously, the body weight of each
rat was recorded.
Sucrose preference test
The sucrose preference test was based on a previous
study [37]. Seventy-two hours before the test, rats
were trained with 1% sucrose solution (w/v); two bot-
tles of 1% sucrose solution were placed in each cage,
and 24 h later, 1% sucrose in one bottle was replaced
with tap water for 24 h. After adaptation, the rats
were deprived of water and food for 24 h, followed
by a sucrose preference test, in which each rat was
placed in an individual metabolic cage that contained
two bottles, one with water and one with 1% sucrose
solution. The test lasted for 1 h. Sucrose preference
was defined as [sucrose intake/(sucrose intake + water
intake)] × 100%.
Hematoxylin-eosin and oil red O staining of the liver.
Fig. 1 Schedule of the procedures used in the present study. The tests included the open-field test (OFT) and sucrose preference test (SPT). CRS,
chronic restraint stress; BW, body weight
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Following fixation of the livers with a 10% formalin/
phosphate-buffered saline, the livers were sliced and
stained with hematoxylin-eosin (HE) for histological
examination. According to the NASH Clinical Research
Network Scoring System [38], liver steatosis was graded
semi-quantitatively based on the percentage of hepato-
cytes according to the following criteria: grade 0, <5% of
hepatocytes involved; grade 1, 5–33% of hepatocytes
involved; grade 2, 34–66% of hepatocytes involved; and
grade 3, >66% of hepatocytes involved. Liver inflamma-
tion was graded based on an overall assessment of all
inflammatory foci according to the following criteria:
grade 0, no foci; grade 1, <2 foci per ×200 field; grade 2,
2–4 foci per ×200 field; and grade 3, >4 foci per ×200
field. Hepatic lipid content was also determined by stain-
ing with oil Red O (Sigma-Aldrich).
Serum biochemical analysis
The serum triglyceride (TG), total cholesterol (TC), ala-
nine aminotransferase (ALT), and aspartate aminotrans-
ferase (AST) levels were measured using an automatic
biochemistry analyzer (CX4/Pro, Beckman Coulter).
Measurement of the hepatic lipids
The livers were homogenized at 4 °C in a lysis buffer
containing 50 mmol/L Tris (pH 8.0), 150 mmol/L NaCl,
1% Triton X-100, and 0.5% sodium deoxycholate. Lipids
from the total liver homogenate were extracted using
the chloroform/methanol method (2:1), evaporated, and
dissolved in 2-propanol.
Measurement of low-density lipoprotein, superoxide dis-
mutase, malondialdehyde, and cytokines
The liver low-density lipoprotein (LDL) level was
estimated using commercially available kits (Jian Cheng
Biological Engineering Institute). A Superoxide Dismutase
Detection Kit (Jian Cheng Biological Engineering Insti-
tute) was selected to measure superoxide dismutase
(SOD) levels. A Malondialdehyde (MDA) Detection Kit
(Jian Cheng Biological Engineering Institute) was selected
to determine the MDA level as a marker of lipid peroxida-
tion. The liver tumor necrosis factor (TNF)-α and
interleukin (IL)-6 levels were determined using an
enzyme-linked immunosorbent assay kit (Cloud-Clone
Corp.). All assays were performed according to the manu-
facturers’ instructions.
Data analysis
Results are shown as a mean ± standard deviation (SD).
Statistical analysis was performed using SPSS 23.0 soft-
ware (SPSS, Inc.). Significant differences between the
groups were evaluated using the Student t-test. For mul-
tiple comparisons, one-way analysis of variance (ANOVA)
was used. If the results of ANOVA indicated significant
differences, post hoc analysis was performed with the
Tukey test or Dunnett test, and p < 0.05 was considered
statistically significant.
Results
Effect of SNS on chronic stress-induced body weight and
stress-related behavior
At the end of the experimental protocol, body weight
gain was significantly lower in the stress group than in
the control group (p < 0.001), and the SNS group had a
higher body weight gain than the stress group (p < 0.01)
(Fig. 2a). The sucrose preference was lower in the stress
group than in the control group (p < 0.001), and the su-
crose preference was higher in the SNS group than in
the stress group (p < 0.001) (Fig. 2b). The numbers of
locomotor (p < 0.001) and rearing (p < 0.01) events in
the OFT were significantly lower in the stress group
than in the control group; however, there was no signifi-
cant difference between the stress group and SNS group
(Fig. 2c, d).
Relationship between chronic stress and steatosis, and
NASH.
The serum TC level had an increasing tendency but was
not statistically significant, and the serum TG level signifi-
cantly increased (p < 0.05) (Fig. 3a, b). Results of quantita-
tive analysis showed a significant increase in the liver
values of FFA (p < 0.05), TG (p < 0.01), TC (p < 0.001),
and LDL (p < 0.01) in stressed rats (Fig. 3c-f). Therefore,
these data suggest that chronic stress can induce liver
steatosis independent of the dietary factor.
Results showed that stressed rats developed exacer-
bated NASH compared to the control rats, as indicated
by increased levels of serum AST (p < 0.001) and ALT
(p < 0.001), and NAFLD activity inflammation scores
(p < 0.01) (Fig. 4a, b). No significant difference was ob-
served in the serum alkaline phosphatase (ALP) level
and AST/ALT ratio between the stress and control
groups (Fig. 4c, d). Regarding the SOD (p < 0.01), MDA
(p < 0.05), and IL-6 (p < 0.01) levels, stressed rats had
higher liver levels than control rats, and concerning the
TNF-α level, no significant increase was observed in the
stress group (Fig. 5a-d).
Effect of SNS on hepatic steatosis and liver injury
In vivo, our results showed that after 9 weeks of
restrained stress, SNS treatment prevented increases in
the levels of serum TC, liver FFA (p < 0.05), and liver
TC (p < 0.05) and TG (p < 0.05) in the chronic stress
condition (Fig. 3c-e). Additionally, no significant change
was observed in the serum TG and liver LDL levels be-
tween the stress and SNS groups (Fig. 3a, f ). The serum
TG level had an increasing tendency in the SNS group
compared to the stress group. Compared to the stress
group, the levels of serum AST (p < 0.001) and ALT














































































Fig. 2 Changes in behavioral indicators after the chronic restraint stress (CRS) procedure and Sinisan (SNS) treatment. a Body weight (BW)
changes after CRS. b The sucrose preference after the CRS procedure and SNS treatment. c, d Open-field test indexes (the number of locomotor
and rearing events) after the CRS procedure and SNS treatment. Values plotted are mean ± standard deviation (N = 10 per group). #p < 0.05,

























































































































Fig. 3 Effects of chronic stress. Chronic stress induces the accumulation of hepatic triglyceride (TG), total cholesterol (TC), free fatty acids (FFA),
and low-density lipoprotein (LDL), and Sinisan (SNS) treatment can decrease this accumulation. a The serum TC level is shown in the bar chart.
b The serum TG level is shown in the bar chart. c The liver FFA level. d, e The liver TG and TC concentrations in each group. f The liver LDL level.
Values plotted are a mean ± standard deviation (N = 10 per group). #p < 0.05, ##p < 0.01, ### p < 0.001 versus the control group, * p < 0.05
versus the stress group
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(p < 0.001) in the SNS group were significantly
decreased (Fig.4 a, b), indicating that SNS may have the
ability to ameliorate NAFLD-related liver injury. No
difference in the serum ALP level was observed among
the groups (Fig. 4d). Chronic stress was confirmed to a
certain degree by histological staining using oil red O
(Fig. 6a). Lastly, according to the pathological analysis,
the liver steatosis and inflammation score indicated that
SNS treatment (p < 0.05) can ameliorate hepatic steato-
sis and NASH (Fig. 6b).
Effect of SNS on hepatic inflammation and oxidative
stress
Lipid accumulation may link oxidative stress to inflam-
mation, forming a feedback loop that significantly aggra-
vates the severity of NAFLD [39]. As shown in Fig. 5d,
compared to the stress group, the SNS group exhibited
decreased levels of pro-inflammatory cytokine IL-6
(p < 0.01). No significant difference was observed in the
levels of SOD, MDA, and TNF-α (Fig. 5a-c), but all these
makers had a normalizing trend.
Discussion
Over the past decade, NAFLD has become one of the
most prevalent causes of chronic liver disease [40]. Ac-
cumulating evidence has shown that psychological stress
may correlate with the increasing incidence of metabolic
syndrome, inflammation, and NAFLD [41, 42]. However,
previous studies mostly concentrated on the effect of
chronic stress on obesity or metabolic syndrome com-
bined with a high-fat diet [43, 44]. In the present study,
the key finding was that rats could develop steatosis and
NASH only during the intervention of chronic stress,
although their body weight gain was decreased. Further-
more, chronic stress exposure can lead to oxidative
stress and a chronic inflammatory state in the liver. To
exclude the dietary factor and other related factors in
this experiment, we chose a mimics restraint stress
model that is largely psychological in nature.
In the current study, the pathological results showed
that hepatic lobule structures were disorderly arranged
in stressed rats. Hepatic steatosis and inflammatory cell
infiltration were also observed. The levels of serum TG
and liver FFA, TC, TG and LDL were significantly in-
creased, suggesting the existence of hepatic fat depos-
ition. Particularly, the increased retention of lipids in
hepatocytes, mostly in the form of TG and TC, is the
common early trait of NAFLD. Additionally, we found
that chronic stress can lead to a high level of serum ALT
and AST, indicating a capacity of chronic stress for
hepatocyte injury. A high level of liver IL-6 and MDA,
and low level of liver SOD were also found. IL-6 is a
pro-inflammatory pleiotropic cytokine produced by adi-































































Fig. 4 The serum activities of three hepatic injury-associated enzymes, alanine aminotransferase, aspartate aminotransferase, and alkaline phosphatase.
a The serum AST level. b The serum ALT level. c The AST and ALT ratio. d The serum ALP level. Values plotted are a mean ± standard deviation
(N = 10 per group). ###p < 0.001 versus the control group, *** p < 0.001 versus the stress group. SNS, Sinisan; ALT, alanine aminotransferase; AST,
aspartate aminotransferase; ALP, alkaline phosphatase
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[45]. Some studies have shown that accumulated FFAs in
hepatocytes activate IκB kinase and nuclear factor-κB, a
transcription factor that plays a central role in coordinat-
ing the expression of various pro-inflammatory cytokines,
including IL-6 [46]. Chronic exposure to IL-6 led to liver
injury, although studies have concluded that it has a pro-
tective role against the progression of hepatic steatosis,
and paradoxically, a hepatocytes protective role in ad-
vanced stages of NAFLD [47, 48]. Additionally, MDA and
SOD are important markers of oxidative stress. However,
MDA is a kind of aldehyde produced through the lipid
peroxidation process, which can promote crosslinking of
nucleic acids, proteins, and phospholipids and change the
function of these biological macromolecules. The level of
lipid peroxidation can be represented by MDA content
[49, 50]. Conversely, SOD can transform superoxide an-
ions into H2O2, thereby eliminating superoxide anions
and protecting cells from oxygen radical injury. Therefore,
SOD is the main factor that protects the liver tissue
against harmful oxidative stress from internal and external
environments [51]. An increased MDA level and de-
creased SOD activity are important signs of increased oxi-
dative stress [52, 53]. Therefore, these results further
confirmed that the second hit was involved in the patho-
genesis of stress-related NAFLD.
In terms of TCM, qi is an active principle forming part
of any living thing. The dredging function of the liver is
extremely important in regulating the flow of Qi and
blood in the body. It is one of the most vulnerable or-
gans to anger, repression, and distress resulting in liver
qi stagnation, which produces typical symptoms of
stress-related disorders. We believe that the theory of
liver qi has some relationship with psychological stress.
In the present study, we found that psychological stress
can lead to NAFLD and even NASH, which means that
the liver may be an organ that stress targets, thus prov-
ing the liver qi theory to some extent. In China, SNS has
a nearly 2000-year history of use for treating patients
with liver qi stagnation, and it has shown some curative
effects. Some studies have shown that SNS is effective
for improving disorders of the digestive system, includ-
ing liver injury [54] and colitis [55]. Theoretically, SNS
may be the most appropriate herb formula for treating
stress-related NAFLD. Therefore, we investigated the
mechanism of SNS for treating NAFLD. Our results
showed that SNS can increase the sucrose preference of
stressed rats, which means that SNS may decrease
anhedonia-like behavior, which is the main symptom of
depression in humans [56]. No significant difference was










































































Fig. 5 The oxidative stress and inflammation of the liver. a The superoxide dismutase (SOD) level of each group. b The tumor necrosis factor
(TNF)-α level of each group. c The malondialdehyde (MDA) level of each group. d The liver interleukin (IL)-6 level of each group. Values plotted
are a mean ± standard deviation (N = 10 per group). #p < 0.05, ##p < 0.01 versus the control group, **p < 0.01 versus the stress group.
SNS, Sinisan
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effect on the activity and excitability of stressed rats. There-
fore, SNS may be a useful anti-stress formula, which is in
agreement with findings from another study on rats [28].
Our data also showed that SNS treatment can significantly
improve hepatic steatosis and reduce the AST and ALT
levels. Moreover, the serum TC level and liver FFA, TC, and
TG levels of the SNS treatment group were significantly de-
creased. Similarly, we found that SNS treatment decreased
the level of liver IL-6, which suggests that the beneficial ef-
fect of SNS on NAFLD may be partly attributable to the
anti-inflammatory effect, including the down-regulated ex-
pression of IL-6. SNS can increase and reduce the SOD and
MDA levels, but this trend was not statistically significant,
suggesting that it is uncertain whether SNS improve
NAFLD by reducing oxidative stress. Overall, the beneficial
effect of SNS involves anti-steatosis and anti-inflammation.
Conclusions
Our study provides new insight into the TCM liver qi
theory and the pathogenesis of NALFD. Our findings
strongly support that psychological stress may be a
significant risk factor of NAFLD, although our experi-
ment could not completely eliminate physical agents.
Furthermore, TCM formula SNS may have some
beneficial effect in antagonizing psychological stress
and stress-related NAFLD. These results serve to
remind physicians that those with long-term psycho-
logical stress may also be at risk for developing
NAFLD, regardless of their weight. To prevent
NAFLD, physicians should concentrate on stress
management and clinically apply the TCM theory and
formula SNS in patients with psychological stress and
NAFLD.
Fig. 6 Photomicrographs of histological changes in the rat liver. a Representative slides show hematoxylin and eosin (HE)-stained and oil red
O-stained liver sections from rats of each group. HE sections show chronic stress causing foci of inflammatory cell infiltration and lipid deposits
(yellow arrows) (original magnification, ×100 and ×400, respectively). b The nonalcoholic fatty liver disease (NAFLD) activity score was evaluated
using the New York NAFLD score system. Values plotted are a mean ± standard deviation (N = 10 per group). ##p < 0.01 versus the control
group, *p < 0.05 versus the stress group
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